Optimi Health Initiates Pathway to Nasdaq Listing

Vancouver, BC – July 7, 2021 — Optimi Health Corp. (OTCQB: OPTHF) (CSE: OPTI) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated developer of mushroom products announced today that it has engaged the consulting services of Donohoe Advisory Associates LLC (“Donohoe Advisory”) to explore strategies to advance towards a potential Nasdaq listing.   Donohoe […]